ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) presented at the 13th Annual Needham Healthcare Conference on April 8, 2014, at 8:40 a.m. Eastern Time in New York City. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares after opening at $20.35 moved to $21.04 on last trade day and at the end of the day closed at $20.55 . Company price to sales ratio in past twelve months was calculated as 1839.41 and price to cash ratio as 10.89. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) showed a positive weekly performance of 6.59%.
Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP) ticking higher on M&A in the pharma sector. Shares are moving comfortably back above the $5 level Thursday. Synergy Pharmaceuticals Inc (NASDAQ:SGYP) shares advanced 10.88% in last trading session and ended the day on $4.89. SGYP return on equity ratio is recorded as -111.60% and its return on assets is -89.10%. Synergy Pharmaceuticals Inc (NASDAQ:SGYP) yearly performance is 3.38%.
Idera Pharmaceuticals (NASDAQ:IDRA) surged Tuesday on a positive day for healthcare stocks after the company had remained relatively flat since last week. Idera Pharmaceuticals Inc (NASDAQ:IDRA) shares moved down -0.60% in last trading session and was closed at $3.29 while trading in range of $3.07 – $3.68 – Idera Pharmaceuticals Inc (NASDAQ:IDRA) year to date (YTD) performance is -28.94%.
Galena Biopharma Inc (NASDAQ:GALE) a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced that the 2014 Award for Excellence in Technology Transfer was granted to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) and the Uniformed Services University of the Health Sciences (USU). Galena Biopharma Inc (NASDAQ:GALE) weekly performance is 22.58%. On last trading day company shares ended up $2.28. Galena Biopharma Inc (NASDAQ:GALE) distance from 50-day simple moving average (SMA50) is -24.82%. Analysts mean target price for the company is $6.67.